trending Market Intelligence /marketintelligence/en/news-insights/trending/s8bcxBmN1Z4kCQWaJ2tg6w2 content esgSubNav
In This List

Murad Chia Jei Biotechnology Q3 profit climbs YOY


Investment Banking Essentials Newsletter: 31st May edition


Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders

Case Study

Central European Broadcaster Monetizes Content with a New Online Streaming Service


Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns

Murad Chia Jei Biotechnology Q3 profit climbs YOY

Murad Chia Jei Biotechnology Co. Ltd. said its normalized net income for the third quarter was 13 Taiwan cents per share, an increase from 6 cents per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was NT$10.6 million, an increase from NT$5.2 million in the prior-year period.

The normalized profit margin rose to 5.6% from 3.3% in the year-earlier period.

Total revenue grew 19.2% on an annual basis to NT$190.5 million from NT$159.7 million, and total operating expenses totaled NT$161.8 million, compared with NT$160.6 million in the year-earlier period.

Reported net income rose 12.0% year over year to NT$7.4 million, or 9 cents per share, from NT$6.6 million, or 8 cents per share.

As of Nov. 16, US$1 was equivalent to NT$32.83.